A Phase I study to assess the safety, pharmacokinetics and efficacy of barasertib (AZD1152), an Aurora B kinase inhibitor, in Japanese patients with advanced acute myeloid leukemia. (Q54590599)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | A Phase I study to assess the safety, pharmacokinetics and efficacy of barasertib (AZD1152), an Aurora B kinase inhibitor, in Japanese patients with advanced acute myeloid leukemia. |
scientific article |
Statements
A Phase I study to assess the safety, pharmacokinetics and efficacy of barasertib (AZD1152), an Aurora B kinase inhibitor, in Japanese patients with advanced acute myeloid leukemia. (English)
Naokuni Uike
Kosuke Tsuboi
Toshiya Yokozawa
Toru Sakura
Takashi Watanabe
Shin Fujisawa
Takahiro Yamauchi
Kiyoshi Ando
Rika Kihara
Kensei Tobinai
Hiroya Asou
Tomomitsu Hotta
Shuichi Miyawaki
11 May 2011
35
10
1384-1389